arcadia

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE539.20-2.15 (-0.4 %)
PREV CLOSE ( ) 541.35
OPEN PRICE ( ) 550.00
BID PRICE (QTY) 539.20 (163)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 68072
TODAY'S LOW / HIGH ( )536.40 550.00
52 WK LOW / HIGH ( )483.75 678
NSE539.65-1.5 (-0.28 %)
PREV CLOSE( ) 541.15
OPEN PRICE ( ) 544.80
BID PRICE (QTY) 539.65 (3746)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1879600
TODAY'S LOW / HIGH( ) 536.75 545.00
52 WK LOW / HIGH ( )483.75 678.45
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 17-08 1935
Management Info
Y K Hamied - Chairman Umang Vohra - Managing Director
Registered Office

Address Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone 022-24826000 / 022-24826951

Email cosecretary@cipla.com

Website www.cipla.com

Registrars Details
Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX
NEWS
19Feb Cipla, NLC India and Emami to see some
Cipla's wholly owned subsidiary Goldencross Pharma has signed an agreeme..
19Feb Cipla's arm to acquire 11.71% stake in
Cipla's wholly owned subsidiary -- Goldencross Pharma has signed an agre..
19Feb Cipla wins portion of state ARV tender
Cipla has been awarded a share of the South African Government's Nationa..
19Feb Cipla gains with arm inking agreement
Cipla is currently trading at Rs. 542.40, up by 1.05 points or 0.19 % fr..
11Feb Cipla's arm completes first stage clos
Cipla's wholly owned subsidiary -- InvaGen Pharmaceuticals Inc., USA has..
Financials
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit2953.214685.2
Gross Profit 4115.1 19114
Operating Profit 5630.325304.3
Net Sales 28352114448.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Fredun Pharma (BSE)
 361.90 (9.70%)
M.Cap ( in Cr)144.38
Themis Medicare (BSE)
 305.00 (8.73%)
M.Cap ( in Cr)280.02
Everest Organics (BSE)
 157.65 (16.86%)
M.Cap ( in Cr)126.12
Pfizer (BSE)
 2907.45 (0.58%)
M.Cap ( in Cr)13300.92
Jenburkt Pharma (BSE)
 474.90 (3.28%)
M.Cap ( in Cr)217.95
Shareholding Pattern
PROMOTERS 36.7%
NON-INSTITUTION 23.69%
MUTUAL FUNDS/UTI 10.9%
FI/BANKS/INSURANCE 2.83%
FII 0.61%
GOVERNMENT 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM